Ownership history in BB BIOTECH AG · 70 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Celgene Corp. Common Stock (CELG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | REDUCED | 2,200,000 | -103,875 | -4.5% | 5.22% | $207.5M | — |
| 2018 Q4 | REDUCED | 2,303,875 | -680,423 | -22.8% | 4.73% | $147.7M | — |
| 2018 Q3 | REDUCED | 2,984,298 | -340,000 | -10.2% | 7.07% | $267.1M | — |
| 2018 Q2 | UNCHANGED | 3,324,298 | — | 0% | 7.62% | $264.0M | — |